“What Marc Beer, CEO Of Renovia Inc. Plans to Do with the $42 Million He Helped Raise “February 27, 2019 - Author: steph
Marc Beer is a man of many talents. He was one of the co-founders of Renovia Inc. where he is also the Chairman and CEO. He raised $42 million to help fund the women’s health startup the company which develops diagnostic and therapeutic devices. These devices are meant to help treat different pelvic floor disorders. The $42 million funding is aimed at helping develop and test four more new products for the company’s goal. Mr. Beer has over 25 years of executive experience having worked in different fields in the pharmaceutical, biotechnology, device, and diagnostic industries.
The funding is also meant to go into the testing and development of a newer generation of the Leva device. Renovia aims to diagnose, treat, and improve the lives of people affected by pelvic floor disorders, particularly women. Combining the innovative and propriety sensor technologies at the disposal of the company and other form factors should see this goal through. Renovia is working to help build a digital health platform that gives customers valuable data and treatment options. By driving greater knowledge and a better understanding of the pelvic floor disorders, the company can ultimately lower the long-term healthcare costs.
Apart from Renovia Inc., Marc Beer has worked at OvaScience as a strategic consultant. He has served as a board member for Erytech Pharma which is a publicly traded biopharmaceutical company. Beer is the founding Chairman of Good Start Genetics’ Inc. board of directors. Good Start Genetics, Inc. is a molecular diagnostics company that is privately held. He has served as the Business Advisory Council of the Miami University and is a former member of Notre Dame Research & Commercialization Advisory Council. These are the few positions that Marc Beer has held throughout his work life in some companies.
The board of Renovia company believes that Mr. Beer’s extensive experiences make him the man for the job as CEO of the company. His time and work in the life sciences industry plus as a board member of numerous life sciences companies qualify him to be the man for the job.
Based on conducted research, it is estimated that around 250 million women worldwide suffer from pelvic floor disorders. One such common disorders include urinary incontinence which can severely hamper and affect the lives of its victims if not diagnosed and treated early. The $42 million funding, therefore, should go a long way towards ensuring that the company achieved its mission and vision. So far, its course is right, and with the support and funding it receives, it should realize its goal. Learn more: https://www.crunchbase.com/person/marc-beer
Marc Beer is a man of action, and the work he is doing at Renovia Inc. proves that he has a lot of potentials. The dedication he has put in his work to help make the world a better place for people suffering from pelvic floor disorders makes him the best at his job.